LYS — Lysogene SA Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Lysogene SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -17.8 | -10.9 | -4.28 | -5.09 | -13.6 |
| Depreciation | |||||
| Non-Cash Items | 1.72 | 1.5 | 2.74 | 1.32 | 0.933 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.11 | 18.4 | 3.69 | -11.1 | -2.13 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -14.9 | 8.99 | 2.39 | -14.5 | -14.4 |
| Capital Expenditures | -0.052 | -0.006 | -0.324 | -0.033 | -0.286 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.322 | 0.023 | -0.113 | -0.001 | 0.091 |
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.374 | 0.017 | -0.437 | -0.034 | -0.195 |
| Financing Cash Flow Items | 0.247 | -0.038 | 0 | 0 | 0.71 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 23.1 | 1.85 | -0.438 | 6.83 | 8.19 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 7.74 | 10.9 | 1.51 | -7.69 | -6.44 |